Hua Medicine (HKSE:02552) GF Value : HK$0.00 (As of Apr. 23, 2025)

View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine GF Value?

As of today (2025-04-23), Hua Medicine's share price is HK$2.14. Hua Medicine's GF Value is HK$0.00. Therefore, Hua Medicine's Price-to-GF-Value for today is . Based on the relationship between the current stock price and the GF Value, GuruFocus believes Hua Medicine is Not Valued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Hua Medicine (HKSE:02552) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (1)
Possible Value Trap, Think Twice	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)	Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.

Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.

Hua Medicine's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	2.14	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hua Medicine GF Value Related Terms

Thank you for viewing the detailed overview of Hua Medicine's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Hua Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (HKSE:02552) » Definitions » GF Value

Traded in Other Exchanges

N/A

Address

Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.huamedicine.com

Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.

Executives

Hong Jane Xingfang	2202 Interest of your spouse
Chen Li	2101 Beneficial owner
Hlyy Limited	2306 Nominee for another person
Tct (bvi) Limited	2501 Other
The Core Trust Company Limited	2301 Trustee
Wuxi Pharmatech Investments (cayman) Inc.	2201 Interest of corporation controlled by you
Wuxi Pharmatech Investment Holdings (cayman) Inc.	2201 Interest of corporation controlled by you
Wuxi Pharmatech Fund I General Partner L.p.	2201 Interest of corporation controlled by you
Wuxi Pharmatech Healthcare Fund I L.p.	2101 Beneficial owner
Wuxi Apptec Co., Ltd.	2201 Interest of corporation controlled by you
Wuxi Apptec International Holdings Limited	2201 Interest of corporation controlled by you
Nelsen Robert Taylor	2101 Beneficial owner
Venrock Management V, Llc	2102 Investment manager
Harvest Yuanxiang (cayman) Limited	2101 Beneficial owner
Arch Venture Fund Vii, L.p.	2101 Beneficial owner

Hua Medicine Headlines

No Headlines